United Capital Management Of Ks, Inc. Pro Phase Labs, Inc. Transaction History
United Capital Management Of Ks, Inc.
- $424 Million
- Q1 2025
A detailed history of United Capital Management Of Ks, Inc. transactions in Pro Phase Labs, Inc. stock. As of the latest transaction made, United Capital Management Of Ks, Inc. holds 34,700 shares of PRPH stock, worth $12,145. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,700
Previous 34,700
-0.0%
Holding current value
$12,145
Previous $26,000
50.0%
% of portfolio
0.0%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding PRPH
# of Institutions
37Shares Held
4.95MCall Options Held
0Put Options Held
0-
Wexford Capital LP Greenwich, CT1.53MShares$533,9630.18% of portfolio
-
Vanguard Group Inc Valley Forge, PA408KShares$142,8930.0% of portfolio
-
Four World Capital Management LLC New York, NY377KShares$131,8010.1% of portfolio
-
Quinn Opportunity Partners LLC Charlottesville, VA318KShares$111,3440.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny300KShares$104,9330.0% of portfolio
About ProPhase Labs, Inc.
- Ticker PRPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 16,024,400
- Market Cap $5.61M
- Description
- ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...